PRF1 and neoplasm: Tumor-derived lactate and the accompanying microenvironment acidification are known to inhibit NK cell effector functions (e.g., the release of perforin, granzyme B, and IFN-γ), downregulate activating receptor expression, and impair cytotoxicity against tumor cells [59,89].